Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Unknown 1Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 2

Conditions

Carcinoma, Non-Small-Cell Lung 147Melanoma 122Breast Neoplasms 98Squamous Cell Carcinoma of Head and Neck 96Triple Negative Breast Neoplasms 85Lung Neoplasms 64Neoplasm Metastasis 53Carcinoma, Renal Cell 49Neoplasms 46Head and Neck Neoplasms 46Colorectal Neoplasms 41Ovarian Neoplasms 38Carcinoma, Transitional Cell 36Carcinoma, Hepatocellular 36Pancreatic Neoplasms 35Urinary Bladder Neoplasms 34Recurrence 33Stomach Neoplasms 32Glioblastoma 30Brain Neoplasms 28Sarcoma 26Endometrial Neoplasms 25Prostatic Neoplasms 23Hodgkin Disease 22Uterine Cervical Neoplasms 19Fallopian Tube Neoplasms 19Carcinoma, Squamous Cell 19Esophageal Squamous Cell Carcinoma 17Adenocarcinoma 17Multiple Myeloma 16

Interventions

Methotrexate 6Dactinomycin 5camrelizumab 3Flow Cytometry 3Drug Therapy 3toripalimab 2pembrolizumab 2apatinib 2Vacuum Curettage 2Psychiatric Rehabilitation 2Methylprednisolone 2Leucovorin 2Immunologic Techniques 2Cyclophosphamide 2Alemtuzumab 2zimberelimab 1dostarlimab 1dexamethasone acetate 1dexamethasone 21-phosphate 1Vincristine 1Tacrolimus 1Surveys and Questionnaires 1Surgical Procedures, Operative 1Prednisone 1Paclitaxel 1Moxifloxacin 1Microarray Analysis 1Methods 1Interleukin-12 Subunit p35 1Interleukin-11 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Gestational Trophoblastic Disease × pembrolizumab × Clear all
NCT05635344 2024-04-17

A Feasibility Window Study of Pembrolizumab Prior to Second Evacuation for Post-molar Gestational Trophoblastic Neoplasia

Imperial College London

Phase 2 Recruiting
20 enrolled
Gynecologic

Recurrence, Gestational Trophoblastic Disease

NCT04303884 2020-03-11

CR-GTP

CHA University

Phase 2 Unknown
15 enrolled
Gynecologic

Gestational Trophoblastic Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡